183 related articles for article (PubMed ID: 25407898)
1. Nucleolar targeting by platinum: p53-independent apoptosis follows rRNA inhibition, cell-cycle arrest, and DNA compaction.
Peterson EJ; Menon VR; Gatti L; Kipping R; Dewasinghe D; Perego P; Povirk LF; Farrell NP
Mol Pharm; 2015 Jan; 12(1):287-97. PubMed ID: 25407898
[TBL] [Abstract][Full Text] [Related]
2. Effects of noncovalent platinum drug-protein interactions on drug efficacy: use of fluorescent conjugates as probes for drug metabolism.
Benedetti BT; Peterson EJ; Kabolizadeh P; Martínez A; Kipping R; Farrell NP
Mol Pharm; 2011 Jun; 8(3):940-8. PubMed ID: 21548575
[TBL] [Abstract][Full Text] [Related]
3. Multi-platinum anti-cancer agents. Substitution-inert compounds for tumor selectivity and new targets.
Farrell NP
Chem Soc Rev; 2015 Dec; 44(24):8773-85. PubMed ID: 25951946
[TBL] [Abstract][Full Text] [Related]
4. Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.
Kasparkova J; Fojta M; Farrell N; Brabec V
Nucleic Acids Res; 2004; 32(18):5546-52. PubMed ID: 15486204
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulfate proteoglycan-mediated entry pathway for charged tri-platinum compounds: differential cellular accumulation mechanisms for platinum.
Silva H; Frézard F; Peterson EJ; Kabolizadeh P; Ryan JJ; Farrell NP
Mol Pharm; 2012 Jun; 9(6):1795-802. PubMed ID: 22494465
[TBL] [Abstract][Full Text] [Related]
6. DNA condensing effects and sequence selectivity of DNA binding of antitumor noncovalent polynuclear platinum complexes.
Malina J; Farrell NP; Brabec V
Inorg Chem; 2014 Feb; 53(3):1662-71. PubMed ID: 24428232
[TBL] [Abstract][Full Text] [Related]
7. Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells.
Hata T; Yamamoto H; Ngan CY; Koi M; Takagi A; Damdinsuren B; Yasui M; Fujie Y; Matsuzaki T; Hemmi H; Xu X; Kitani K; Seki Y; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Mol Cancer Ther; 2005 Oct; 4(10):1585-94. PubMed ID: 16227409
[TBL] [Abstract][Full Text] [Related]
8. Rapid onset of nucleolar disintegration preceding cell cycle arrest in roscovitine-induced apoptosis of human MCF-7 breast cancer cells.
Wojciechowski J; Horky M; Gueorguieva M; Węsierska-Gądek J
Int J Cancer; 2003 Sep; 106(4):486-495. PubMed ID: 12845642
[TBL] [Abstract][Full Text] [Related]
9. Novel tacrine platinum(II) complexes display high anticancer activity via inhibition of telomerase activity, dysfunction of mitochondria, and activation of the p53 signaling pathway.
Qin QP; Wang SL; Tan MX; Wang ZF; Luo DM; Zou BQ; Liu YC; Yao PF; Liang H
Eur J Med Chem; 2018 Oct; 158():106-122. PubMed ID: 30205260
[TBL] [Abstract][Full Text] [Related]
10. Biological consequences of trinuclear platinum complexes: comparison of [[trans-PtCl(NH3)2]2mu-(trans-Pt(NH3)2(H2N(CH2)6-NH2)2)]4+ (BBR 3464) with its noncovalent congeners.
Harris AL; Ryan JJ; Farrell N
Mol Pharmacol; 2006 Feb; 69(2):666-72. PubMed ID: 16275707
[TBL] [Abstract][Full Text] [Related]
11. Higher anti-tumour efficacy of platinum(IV) complex LA-12 is associated with its ability to bypass M-phase entry block induced in oxaliplatin-treated human colon cancer cells.
Vondálová Blanářová O; Jelínková I; Hyršlová Vaculová A; Sova P; Hofmanová J; Kozubík A
Cell Prolif; 2013 Dec; 46(6):665-76. PubMed ID: 24118195
[TBL] [Abstract][Full Text] [Related]
12. Ligand modulation of a dinuclear platinum compound leads to mechanistic differences in cell cycle progression and arrest.
Menon VR; Peterson EJ; Valerie K; Farrell NP; Povirk LF
Biochem Pharmacol; 2013 Dec; 86(12):1708-20. PubMed ID: 24161784
[TBL] [Abstract][Full Text] [Related]
13. A novel star-shaped trinuclear platinum(II) complex based on a 1,3,5-triazine core displaying potent antiproliferative activity against TNBC by the mitochondrial injury and DNA damage mechanism.
Wu Y; Zhao D; Shang J; Huang W; Chen Z
Dalton Trans; 2022 Jul; 51(29):10930-10942. PubMed ID: 35731536
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, crystal structures and antitumor activity of two platinum(II) complexes with methyl hydrazinecarbodithioate derivatives of indolin-2-one.
Li YS; Peng B; Ma L; Cao SL; Bai LL; Yang CR; Wan CQ; Yan HJ; Ding PP; Li ZF; Liao J; Meng YY; Wang HL; Li J; Xu X
Eur J Med Chem; 2017 Feb; 127():137-146. PubMed ID: 28039772
[TBL] [Abstract][Full Text] [Related]
15. The role of p53 in the cellular toxicity by active trans-platinum complexes containing isopropylamine and hydroxymethylpyridine.
Ramos-Lima FJ; Moneo V; Quiroga AG; Carnero A; Navarro-Ranninger C
Eur J Med Chem; 2010 Jan; 45(1):134-41. PubMed ID: 19853978
[TBL] [Abstract][Full Text] [Related]
16. Substitution-inert trinuclear platinum complexes efficiently condense/aggregate nucleic acids and inhibit enzymatic activity.
Malina J; Farrell NP; Brabec V
Angew Chem Int Ed Engl; 2014 Nov; 53(47):12812-6. PubMed ID: 25256921
[TBL] [Abstract][Full Text] [Related]
17. The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines.
Bajbouj K; Schulze-Luehrmann J; Diermeier S; Amin A; Schneider-Stock R
BMC Complement Altern Med; 2012 May; 12():69. PubMed ID: 22640402
[TBL] [Abstract][Full Text] [Related]
18. Substitution-inert polynuclear platinum complexes and Glycosaminoglycans: A molecular dynamics study of its non-covalent interactions.
Rosa NMP; Ferreira FHDC; Farrell NP; Costa LAS
J Inorg Biochem; 2022 Jul; 232():111811. PubMed ID: 35367819
[TBL] [Abstract][Full Text] [Related]
19. A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts.
Pratesi G; Perego P; Polizzi D; Righetti SC; Supino R; Caserini C; Manzotti C; Giuliani FC; Pezzoni G; Tognella S; Spinelli S; Farrell N; Zunino F
Br J Cancer; 1999 Aug; 80(12):1912-9. PubMed ID: 10471039
[TBL] [Abstract][Full Text] [Related]
20. Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines.
Roberts JD; Peroutka J; Beggiolin G; Manzotti C; Piazzoni L; Farrell N
J Inorg Biochem; 1999 Oct; 77(1-2):47-50. PubMed ID: 10626353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
